Amiodarone-induced thyrotoxicosis: Should surgery be considered?

Area of Science:

• Cardiology
• Endocrinology
• Thyroidology

Background:

• Amiodarone, a common antiarrhythmic, causes thyrotoxicosis in 15-20% of users.
• Thyrotoxicosis from amiodarone presents as hyperthyroidism or hypothyroidism.
• Diagnosis involves low TSH and elevated T3/T4 levels.

Purpose of the Study:

• To review amiodarone-induced thyrotoxicosis (AIT).
• To analyze the impact of surgical intervention for AIT.
• To propose early surgery as a primary treatment option for specific AIT patient groups.

Main Methods:

• Literature review on amiodarone-induced thyrotoxicosis.
• Analysis of existing studies on the efficacy and safety of surgery for AIT.
• Evaluation of predictive factors for adverse cardiovascular events in AIT patients.

Main Results:

• Amiodarone-induced thyrotoxicosis requires careful management.
• Medical treatments may be ineffective for some patients.
• Low left ventricular ejection fraction and prolonged diagnosis-to-euthyroid interval predict adverse cardiovascular events.

Conclusions:

• Early surgical intervention should be considered for patients with ineffective medical treatment or left ventricular ejection fraction <40%.
• Surgical morbidity in expert centers is comparable to other thyroidectomy indications.
• Surgery offers a timely resolution for refractory amiodarone-induced thyrotoxicosis.